Yonhap Infomax NewsJan 22
Samsung Biologics posted record operating profit and revenue in 2025, targets 5 trillion won milestone as Plant 5 and U.S. expansion drive further growth.
#YonhapInfomax #SamsungBiologics #OperatingProfit #CDMOBusiness #Plant5 #RevenueGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101459
Samsung Biologics Eyes Another Industry First This Year—Aims for ‘5 Trillion Won Club’

Samsung Biologics posted record operating profit and revenue in 2025, targets 5 trillion won milestone as Plant 5 and U.S. expansion drive further growth.

Yonhap Infomax
Yonhap Infomax NewsOct 9
Samsung Biologics CEO John Rim unveiled the ExellenS CMO brand, emphasizing rapid, consistent-quality supply, and outlined expansion plans in Japan and the US.
#YonhapInfomax #SamsungBiologics #ExellenS #CDMO #Plant5 #JapanMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84883
John Rim, CEO of Samsung Biologics – 'Rapid Delivery to Clients with Consistent Quality'

Samsung Biologics CEO John Rim unveiled the ExellenS CMO brand, emphasizing rapid, consistent-quality supply, and outlined expansion plans in Japan and the US.

Yonhap Infomax